These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10345874)

  • 1. Texas PMPM rates, utilization data reveal wide fluctuations.
    Capitation Rates Data; 1999 Jan; 4(1):5-6. PubMed ID: 10345874
    [No Abstract]   [Full Text] [Related]  

  • 2. Capitation building momentum in latest MGMA group practice data.
    Capitation Manag Rep; 2003 May; 10(5):75-9. PubMed ID: 12800612
    [No Abstract]   [Full Text] [Related]  

  • 3. With nearly all revenue at risk, CA group thrives.
    Capitation Rates Data; 2003 Oct; 8(10):111-2. PubMed ID: 14621546
    [No Abstract]   [Full Text] [Related]  

  • 4. Check these rates for across-the-board comparison of California groups.
    Capitation Rates Data; 2004 Aug; 9(8):89-90. PubMed ID: 15487583
    [No Abstract]   [Full Text] [Related]  

  • 5. Identify cost drivers to bring cap contracts into the black.
    Capitation Manag Rep; 2003 Aug; 10(8):105-9. PubMed ID: 12966694
    [No Abstract]   [Full Text] [Related]  

  • 6. Compensation monitor. Risk contracts help medical groups' bottom line.
    Manag Care; 2008 Dec; 17(12):11. PubMed ID: 19127759
    [No Abstract]   [Full Text] [Related]  

  • 7. MGMA data reveal higher revenues for heavily capitated groups.
    Capitation Manag Rep; 2001 Feb; 8(2):30, 17. PubMed ID: 11234363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shrinkage in risk contracting 'less than expected,' survey finds.
    Capitation Manag Rep; 2002 Jun; 9(6):88-91, 81. PubMed ID: 12154558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1999 Capitation Survey--PMPM rates, utilization benchmarks, stop-loss data, industry trends.
    Capitation Manag Rep; 2000 Jan; 7(1):suppl 1-17. PubMed ID: 11183290
    [No Abstract]   [Full Text] [Related]  

  • 10. Sample capitation rates provide PMPM benchmarks for senior, commercial plans.
    Capitation Rates Data; 1997; 2():42. PubMed ID: 11066333
    [No Abstract]   [Full Text] [Related]  

  • 11. A mixed bag of PMPM rates for this OK multispecialty group.
    Capitation Manag Rep; 2000 Nov; 7(11):166-7. PubMed ID: 11188276
    [No Abstract]   [Full Text] [Related]  

  • 12. How one group of specialists is coping with capitation.
    Mangan D
    Med Econ; 1994 Aug; 71(16):132-4, 136. PubMed ID: 10136133
    [No Abstract]   [Full Text] [Related]  

  • 13. Infrastructure issues hold key to future success under risk.
    Capitation Manag Rep; 2001 Aug; 8(8):113-7. PubMed ID: 11534368
    [No Abstract]   [Full Text] [Related]  

  • 14. Balancing services and risk in claims payments.
    Wakefield B; LaTulippe D
    Health Manag Technol; 1999 Nov; 20(10):18. PubMed ID: 10622869
    [No Abstract]   [Full Text] [Related]  

  • 15. Zero-based budgeting eases the transition to specialty capitation.
    Capitation Manag Rep; 1999 Feb; 6(2):22-5. PubMed ID: 10350830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capitation's technical component: a potential deal-breaker.
    Capitation Manag Rep; 1999 Feb; 6(2):20-2. PubMed ID: 10350829
    [No Abstract]   [Full Text] [Related]  

  • 17. Midwest multispecialty group turns profit on these cap rates.
    Capitation Rates Data; 2002 Aug; 7(8):87-8. PubMed ID: 12357968
    [No Abstract]   [Full Text] [Related]  

  • 18. Careful oversight helps CA group to profit under cap.
    Capitation Rates Data; 2002 Feb; 7(2):18-9. PubMed ID: 11881399
    [No Abstract]   [Full Text] [Related]  

  • 19. Use this checklist to assess your readiness for risk.
    Capitation Manag Rep; 2000 May; 7(5):73-4. PubMed ID: 11066944
    [No Abstract]   [Full Text] [Related]  

  • 20. Single specialty capitation tough, but survivors prosper.
    Capitation Manag Rep; 2002 Oct; 9(10):145-50. PubMed ID: 12412319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.